KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Shares Outstanding (Diluted Average) (2016 - 2025)

Petmed Express' Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $20.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.49% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $20.9 million, changed 0.49%, while the annual FY2025 figure was $20.6 million, 0.98% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $20.9 million in Q4 2025 per PETS's latest filing, roughly flat from $20.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $21.0 million in Q4 2024 to a low of $20.1 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $20.5 million, with a median of $20.4 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): dropped 1.09% in 2022, then grew 3.0% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $20.3 million in 2021, then increased by 0.05% to $20.3 million in 2022, then increased by 0.2% to $20.4 million in 2023, then rose by 2.98% to $21.0 million in 2024, then fell by 0.49% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Shares Outstanding (Diluted Average) are $20.9 million (Q4 2025), $20.9 million (Q3 2025), and $20.8 million (Q2 2025).